Home » Health » Vallée Sud Bio Parc, incubator dedicated to health in Fontenay-aux-Roses

Vallée Sud Bio Parc, incubator dedicated to health in Fontenay-aux-Roses

The regional public establishment Vallée Sud-Grand Paris, south of Hauts-de-Seine, has decided to promote the health sector by launching an incubator for innovative companies in this sector in Fontenay-aux-Roses. “This approach is part of the territory’s business development strategy and its historic collaboration with two research structures, the Atomic Energy Commission and the Institute for Radiation Protection and Nuclear Safety (IRSN) located in proximity ”, indicates Sandrine Degos, founder of the consulting firm Care Insight, responsible for managing the accelerator. The objective is to attract innovative projects in health and biotechnology.

The Vallée Sud Bio Parc incubator will support 10 to 15 start-ups for three years to help them develop their business. “We are addressing companies that are in the acceleration phase. It is not a question of helping the creation of companies, because the offer of support in Ile-de-France is already very important, whether it is that of the poles of competitiveness or that of other incubators. On the other hand, the offer is less for those who are wondering how to manage their growth, how to properly structure their team, define their financing, distribution and even internationalization strategy ”, observes the director.

“We are addressing companies that are in the acceleration phase. How to manage their growth, how to properly structure their team, define their financing, distribution and even internationalization strategy ”

1,500 m² of offices are planned on the site to accommodate start-ups. They will also benefit from the expertise of Care Insight, via personalized support programs, according to the needs of each company. “We will offer them to establish a diagnosis to define the areas on which to work, and we will then coach them for one to three years,” continues the founder of Care Insight. The work will also be collective. The teams will work together on common themes: health financing models, market access, the legal framework for medical devices, etc. Meetings and conferences will be organized to present the companies to potential investors.

“To assess the applications, the jury will take into account the innovative nature of the company, its degree of maturity, its economic and financial viability”

The call for applications closes on July 9. To assess the applications, the jury, made up of representatives of the community, CEA, IRSN and Care Insight, will take into account the innovative nature of the company, its degree of maturity, and its economic and financial viability. A first recruit has already been selected: Life & Soft, specializing in data analysis. “This company co-develops projects and products with the CEA and benefits in particular from the use of its benches and equipment, underlines Sandrine Degos. Setting up close to the company’s teams is a plus for strengthening synergy by benefiting from support and offices located just opposite. ”

A. T.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.